Molecule Details
InChIKeyHVRWZFQFSQUILC-UHFFFAOYSA-N
Compound NameUnii-XX8E5WP7FS
Canonical SMILESCOc1ccc(COc2ccc(Cn3c(N)nc4cc(-c5cnn(C)c5)cnc43)cc2OC)cc1
Clinical Status Data-mined Candidate
Targets (Human+Pathogen)4
Pfam Stratification Homologous
Avg pChEMBL9.38
SourceChEMBL;BindingDB
2D Structure
2D structure
Activity Profile
DrugBank Annotations
DrugBank ID DB16056
Drug NameGZ-389988
CAS Number1788906-96-6
Groups investigational
ATC Codes nan
DescriptionGZ-389988 is under investigation in clinical trial NCT02845271 (Proof-of-concept Study to Assess the Efficacy, Tolerability and Safety of a Single Intraarticular Dose of GZ389988 Versus Placebo in Patients With Painful Osteoarthritis of the Knee).

Cross-references: BindingDB: 164901 CHEMBL3673452 ChemSpider: 58937169 ZINC: ZINC000473215300
Target Activities (4)
Target Gene Organism Category Pfam pChEMBL Type Source
Q16620 NTRK2 Homo sapiens Human PF07679 PF13855 PF16920 PF01462 PF07714 10.0 IC50 ChEMBL;BindingDB
P04629 NTRK1 Homo sapiens Human PF13855 PF16920 PF07714 PF18613 9.5 IC50 ChEMBL;BindingDB
Q16288 NTRK3 Homo sapiens Human PF07679 PF00047 PF13855 PF16920 PF01462 PF07714 9.3 IC50 ChEMBL;BindingDB
P07333 CSF1R Homo sapiens Human PF00047 PF25305 PF07714 8.7 IC50 ChEMBL;BindingDB
DrugBank Target Actions (3)
Target Gene Target Name Action Type
P04629 NTRK1 High affinity nerve growth factor receptor inhibitor targets
Q16288 NTRK3 NT-3 growth factor receptor inhibitor targets
Q16620 NTRK2 BDNF/NT-3 growth factors receptor inhibitor targets